Skip to main content
OpenTrials
Completed

NCT Number: NCT04885543

COVID-19 STAndard of Care in Sub-Saharan Africa

This study was conducted in three African countries on four COVID-19 care centers (CCCs). The CCCs were set up in collaboration with a medical NGO with long experience in recording and monitoring data for cohorts and clinical trials in emergency contexts. The data were recorded using the WHO COVID-19 rapid core case report form.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Tengandogo, Ouagadougou, Burkina Faso

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • SARS-CoV-2 positive at RT-PCR

Exclusion criteria

  • Asymptomatic patients

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: During hospitalization, with an average of 11 days

    In hospital mortality

Secondary outcomes

  1. Clinical worsening

    Time frame: Hospitalization, with an average of 11 days

    Combination of an SpO2 <94% at least once during follow-up (including at baseline), use of oxygen therapy at any time during follow-up, or death

Sponsors and collaborators

Lead sponsor

Alliance for International Medical Action

Other

Registry information

Official study title

Observational Study of the Clinico-biological Evolution and the Standard of Care Offered to Symptomatic Covid-19 Patients in Sub-Saharan Africa

Acronym: COVISTA

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 13, 2021
Registry last updated
May 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.